Ampicillin-sulbactam
Sponsors
Wyeth is now a wholly owned subsidiary of Pfizer, University of Bologna, Attikon Hospital, University of Roma La Sapienza, Rambam Health Care Campus
Conditions
Acinetobacter BacteremiaAcinetobacter Baumannii-calcoaceticus ComplexAcinetobacter PneumoniaAortic Aneurysm and DissectionCarbapenem Resistant Bacterial InfectionCardiac Valve DiseaseCesarean Section; InfectionCholelithiasis
Phase 3
Cefepime and Unictam on Preventing Post-Cesarean Surgical Site Infections
NCT06048692
Start: 2023-01-01End: 2023-09-20Updated: 2023-09-21
Efficacy and Safety of BV100 Plus Low Dose Polymyxin B Versus Colistin Plus High-dose Ampicillin/Sulbactam in Patients With Hospital-acquired or Ventilator-associated Bacterial Pneumonia Due to Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complex
Not yet recruitingNCT07326540
Start: 2026-03-20End: 2028-03-30Target: 248Updated: 2026-01-08
Phase 4
Study Comparing the Safety and Efficacy of Tigecycline With Ampicillin-Sulbactam or Amoxicillin-Clavulanate to Treat Skin Infections
CompletedNCT00368537
Start: 2006-09-30End: 2008-09-30Updated: 2012-08-09
T.E.A. Study Three Days Ertapenem Versus Three Days Ampicillin- Sulbactam
CompletedNCT00630513
Start: 2008-01-31End: 2010-12-31Updated: 2011-08-18
Ampicillin/Sulbactam Versus Cefuroxime as Antimicrobial Prophylaxis for Cesarean Section
CompletedNCT01138852
Start: 2004-07-31End: 2008-12-31Updated: 2010-06-07
Antibiotic Prophylaxis in Laparoscopic Cholecystectomy
TerminatedNCT01888822
Start: 2013-06-30End: 2017-06-30Updated: 2020-03-25
Cefiderocol and Ampicillin-sulbactam vs. Colistin +/- Meropenem for Carbapenem Resistant A. Baumannii
RecruitingNCT05922124
Start: 2024-09-01End: 2026-09-30Target: 734Updated: 2025-08-01